about
Release and effects of prostaglandins in adipose tissue.Resveratrol in metabolic health: an overview of the current evidence and perspectives.The effect of weight loss on serum mannose-binding lectin levels.Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men.Human adipose tissue macrophages are enhanced but changed to an anti-inflammatory profile in obesity.Artificial sweeteners: a place in the field of functional foods? Focus on obesity and related metabolic disorders.Sugar-sweetened beverages and cardio-metabolic disease risks.Effects of long-term total fasting and insulin on ob gene expression in obese patients.Effects of LPS and dietary free fatty acids on MCP-1 in 3T3-L1 adipocytes and macrophages in vitroPreoperative glucocorticoid use and risk of postoperative bleeding and infection after gastric bypass surgery for the treatment of obesity.Amino acid supplementation is anabolic during the acute phase of endotoxin-induced inflammation: A human randomized crossover trial.Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro.Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants.Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial.Estrogen reduces pro-inflammatory cytokines in rodent adipose tissue: studies in vivo and in vitro.Growth hormone-mediated breakdown of body fat: effects of GH on lipases in adipose tissue and skeletal muscle of old rats fed different diets.Stimulation of PAI-1 and adipokines by glucose in human adipose tissue in vitro.Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients.Investigations of the anti-inflammatory effects of vitamin D in adipose tissue: results from an in vitro study and a randomized controlled trial.Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis.Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.Weight history of patients with newly diagnosed Type 2 diabetes.Effects on food intake and blood lipids of cannabinoid receptor 1 antagonist treatment in lean rats.Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy.Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial.Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study.Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2.Pro- and mature IGF-II during diet-induced weight loss in obese subjects.Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects.Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy.Comparable reduction of the visceral adipose tissue depot after a diet-induced weight loss with or without aerobic exercise in obese subjects: a 12-week randomized intervention study.Expression of vitamin D-metabolizing enzymes in human adipose tissue -- the effect of obesity and diet-induced weight loss.Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus.Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots.Inhibition of renal ornithine decarboxylase activity fails to reduce kidney size and urinary albumin excretion in diabetic rats with manifest kidney hypertrophy.Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss.Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects.Intrahepatic fat content correlates with soluble CD163 in relation to weight loss induced by Roux-en-Y gastric bypass.
P50
Q34293783-C60B0930-E37C-4C1F-81DD-5EFB48DE910CQ34357570-9BC2C4AA-C8F1-4290-8C3A-83E4B83DF80CQ36438888-C1200D78-A818-4FDE-AD8C-7996347FBB2AQ37194827-F90AB08A-28C7-4898-95E4-02337718E94DQ37704756-0CD42D5C-856C-4E53-939C-F8980F54906DQ38049507-8D3978E9-18D2-4A8F-9CE2-4241B3DBE643Q38102545-4B20A3C1-FAB2-41BF-B58C-F43392F06BCAQ38342521-B80B82F2-F965-440F-867E-60676AA7F6F2Q38600016-937DA6C8-7CF9-43C6-A8D8-BEDEDF5BE3ADQ41206932-E2B5A677-DED6-4076-841B-AA3DE54F0006Q41304391-69AFF9CC-C7AA-4CB7-B459-D1695A7B4D32Q42712597-1D38A58C-EDC6-4DE9-9B64-AAA4A9BA3429Q43040907-D8611FE1-CBF4-49E1-AFB9-F32E87B1BCE7Q44214246-6983F051-2D81-4F04-96F4-214A1240EF39Q44432400-54BB4622-32CC-4518-9551-87EECEAD6EE8Q44460728-19C36DA5-6C93-4A5B-A578-1A3175EB0A12Q44612298-A66B4348-2995-4F68-A268-85D58AB002F6Q44756450-E2099542-493F-439E-99C2-37A485550BDBQ44806527-00E704F4-703D-4F89-BDF6-6208EDC31B61Q45081182-65D3C94F-FC6C-403C-BF5F-9A83203C713FQ46146375-B5213100-613D-4580-9094-A60768AE04B6Q46286317-720C9E63-03C8-4166-98DA-1BF068279618Q46417018-55FE8772-2A6B-4DA8-9468-D081BD816524Q46609766-F0699BDF-C7D6-4F7E-9ACB-DA3BDD7218B4Q46671681-302920E1-A340-4E6F-A4D0-BD4BDB6FAAC2Q46779241-DB764954-22C3-4BF2-B4BF-77F7A1CECBE1Q46784156-96EC2476-D716-4EE9-8C1A-EFBF7A0C884CQ46797578-ADD073F6-AF18-4708-A65B-BF74919E9981Q46831292-DCBD0B78-5130-4EE0-838C-0BA5538E9C18Q46849818-65487DC1-D8A4-4751-A6D2-4BDDEAC91864Q46861769-329BA61C-B265-4476-A25E-1FCD5DFC3415Q46901722-03600C6E-5F14-4955-9992-C51472DF6456Q47195970-66192337-7933-4E58-A57F-E3B92B2D4F52Q47295734-8F82B963-CC61-451E-BE42-26EBAC5BFBAAQ47330010-1FE3489B-FAE9-4698-A6C4-DB0466614F78Q47348856-249267C0-8A2D-4C5A-A7BA-142A8BD00353Q47363252-442BEB9C-D688-4C94-B0A3-4AA96A25EAE4Q47390763-AD1E9038-575B-4A2C-8385-193D9E1A29B2Q47402154-4321DE36-A3BF-4A64-9467-FD2F09507C11Q47426766-300557AB-058C-4FCD-B206-BAE7C97CD5C1
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7052-9127
@en
name
Bjørn Richelsen
@ast
Bjørn Richelsen
@de
Bjørn Richelsen
@en
Bjørn Richelsen
@es
Bjørn Richelsen
@nl
type
label
Bjørn Richelsen
@ast
Bjørn Richelsen
@de
Bjørn Richelsen
@en
Bjørn Richelsen
@es
Bjørn Richelsen
@nl
prefLabel
Bjørn Richelsen
@ast
Bjørn Richelsen
@de
Bjørn Richelsen
@en
Bjørn Richelsen
@es
Bjørn Richelsen
@nl
P106
P1153
7005987262
P21
P31
P496
0000-0001-7052-9127